1
Return

Microglial LNK regulates metabolic reprogramming via competitively inhibiting OTUB1 binding to PKM2 and mitigates ischemic stroke

delete2026-07-25
delete0
delete
OA
AI
J
Jie Zhao
X
Xin Wei
R
Ranran Li
Z
Zhijie Zhu
X
Xinhui Zhao
J
Jiahui Wang
Z
Z Liu
Y
Yanyang Chen
T
Tengteng Han
W
Wei Li *
W
Weijuan Gong *
L
Li Qian *
DOI:10.1016/j.apsb.2026.07.038delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Microglia-mediated neuroinflammation plays a key role in the process of ischemic stroke. Lymphocyte adaptor protein (LNK) negatively regulates cytokine signaling in peripheral immune cells, but its roles in neuroinflammation and ischemic stroke remain unknown. Here, we demonstrated that LNK expression was decreased in peripheral blood mononuclear cells and microglia after stroke in humans and mice, respectively. Microglia-specific knockout of LNK in mice promoted neuroinflammation and exacerbated ischemia‒reperfusion (I/R) injury in a mouse model of ischemic stroke. Mechanistically, LNK and pyruvate kinase M2 (PKM2) can competitively bind to the OTU deubiquitinase, ubiquitin aldehyde binding 1 (OTUB1), and promote the ubiquitination and degradation of PKM2. In the case of LNK deficiency, OTUB1 can bind to PKM2 and increase its stability, which promotes microglial glycolysis and lactate secretion, enhances the expression of H4K12la and proinflammatory cytokines, and ultimately, worsens brain I/R injury. On the basis of these findings, a PKM2 inhibitor was shown to reduce brain I/R injury exacerbated by LNK deficiency. Moreover, adenovirus-mediated LNK overexpression significantly protected against brain I/R injury in a mouse model of ischemic stroke. Therefore, our study reveals a new function of LNK, which acts as a competitive inhibitory molecule to exert negative regulation, thereby determining stroke outcomes.
Keywords:
Ischemic stroke
I/R
Microglia
LNK
PKM2
OTUB1
Neuroinflammation
H4K12la
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Acta Pharmaceutica Sinica B cover
Acta Pharmaceutica Sinica B
IF:
14.6
Papers:
2.6K
Citations:
2.1W

Organization

A
affiliated hospital of yangzhou university
Scholars:
17
Papers: 11
Citations: 0
Y
yangzhou university
Scholars:
7.3K
Papers: 2.3K
Citations: 2
Cited Papers

Cited Papers

Citing Papers

Citing Papers